2m 2m 2m 2m 2m 2m 2m
RHYTHM PHARM (RYTM)
NASDAQ
$110.01+$0.01 (+0.009%)
Price as of Aug 21, 2026 7:30 PM EDT- $7.6BMarket Cap
- 6.52%1-Year Change
- BiotechnologyIndustry
RHYTHM PHARM (RYTM)
$110.01+$0.01 (+0.009%)
RYTM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $110.00 | ||
Change | +$1.08 (+0.99%) | ||
Open | $109.38 | ||
High | $112.59 | ||
Low | $106.58 | ||
Previous Close | $108.92 | ||
Volume | 523,138 | ||
30-Day Average Volume | 686,541 | ||
1-Week Change | -4.75% | ||
1-Month Change | 3.19% | ||
1-Year Change | 6.52% | ||
3-Year Change | 326.03% | ||
5-Year Change | 782.83% | ||
Fundamentals | |||
Shares Outstanding | 68.9M | ||
Total Assets | $437.3M | ||
Market Cap | $7.6B | ||
Enterprise Value | $7.6B | ||
Period: QTR TTM FY | |||
Revenue | $71.3M | ||
Net Income | -$49.3M | ||
Free Cash Flow | -$9.2M | ||
EBIT | -$48.9M | ||
EBITDA | -$48.7M | ||
Net Working Capital | $303.0M | ||
EPS | -$0.73 | ||
Enterprise Value/EBITDA | -156 | ||
Enterprise Value/Revenue | 107 | ||
P/B | 74 | ||
P/E | -151 | ||
PEG | -13 | ||
Price/Free Cash Flow | -828 | ||
Price/Operating Cash Flow | -828 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue